Micromet Inc. Takeover under Investor Investigation

Feb. 1, 2012 - PRLog -- The Shareholders Foundation announces that an investigation for investors in Micromet Inc.  shares was initiated concerning whether the offer to acquire Micromet for $11 per share and the buyout process are unfair to investors in NASDAQ-MITI shares.

If you are a current investor in Micromet Inc.  and purchased your NASDAQ-MITI shares prior to the announcement, you have certain options and you should contact the Shareholders Foundation at mail(at)shareholdersfoundation.com or call +1(858) 779 – 1554.

The investigations by law firms concern whether Micromet Inc, certain officers and directors, and/or others breached their fiduciary duties to Micromet  investors in connection with the proposed acquisition.

On Jan. 26, 2012, Amgen  and Micromet, Inc.  announced that the companies have entered into a merger agreement under which Amgen will acquire Micromet for $11 per share in cash or a transaction, which values Micromet at approximately $1.16 billion.

Following the takeover announcement shares of Micromet Inc. (MITI) jumped from $.827 on Wednesday to $10.94 on Thursday.

However, at least on analyst has set the high target price for NASDAQ-MITI shares at $12 per share, thus above the current offer.

Those who are current investors in Micromet Inc.  and purchased your NASDAQ-MITI shares prior to the announcement, have certain options and should contact the Shareholders Foundation.

# # #

The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, , which does research related to shareholder issues and informs investors of securities class actions, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.